135 related articles for article (PubMed ID: 1544874)
1. c-Myc interferes with the commitment to differentiation of murine erythroleukemia cells at a reversible point.
Takada S; Yamamoto T; Ohmori Y; Matsui Y; Obinata M
Jpn J Cancer Res; 1992 Jan; 83(1):61-5. PubMed ID: 1544874
[TBL] [Abstract][Full Text] [Related]
2. Probability that the commitment of murine erythroleukemia cell differentiation is determined by the c-myc level.
Kume TU; Takada S; Obinata M
J Mol Biol; 1988 Aug; 202(4):779-86. PubMed ID: 3172238
[TBL] [Abstract][Full Text] [Related]
3. A balance between self-renewal and commitment in the murine erythroleukemia cells with the transferred c-myc gene; an in vitro stochastic model.
Yamamoto T; Masuko K; Takada S; Kume TU; Obinata M
Cell Differ Dev; 1989 Nov; 28(2):129-33. PubMed ID: 2692787
[TBL] [Abstract][Full Text] [Related]
4. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells.
Ohmori Y; Tanabe J; Takada S; Lee WM; Obinata M
Oncogene; 1993 Feb; 8(2):379-86. PubMed ID: 8426744
[TBL] [Abstract][Full Text] [Related]
5. Role of c-Myc on erythroid differentiation.
Ohmori Y; Tanabe J; Terashima M; Shoji W; Takada S; Obinata M
Tohoku J Exp Med; 1992 Oct; 168(2):203-10. PubMed ID: 1306305
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-Myc inhibits the appearance of a specific DNase I hypersensitive site in the beta-globin chromatin in murine erythroleukemia cells.
Takada S; Obinata M
Jpn J Cancer Res; 1991 Apr; 82(4):376-9. PubMed ID: 1904416
[TBL] [Abstract][Full Text] [Related]
7. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate.
Lachman HM; Cheng GH; Skoultchi AI
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6480-4. PubMed ID: 3529085
[TBL] [Abstract][Full Text] [Related]
8. Induction of glycophorin gene expression in cultured murine erythroleukemia cells.
Matsui Y; Natori S; Obinata M
Differentiation; 1985; 29(3):268-74. PubMed ID: 3908202
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-dependent repression of c-myc, B22, COX II and COX IV genes in murine erythroleukemia (MEL) cells.
Vizirianakis IS; Pappas IS; Tsiftsoglou AS
Biochem Pharmacol; 2002 Mar; 63(5):1009-17. PubMed ID: 11911854
[TBL] [Abstract][Full Text] [Related]
11. Antisense RNA of the latent period gene (MER5) inhibits the differentiation of murine erythroleukemia cells.
Nemoto Y; Yamamoto T; Takada S; Matsui Y; Obinata M
Gene; 1990 Jul; 91(2):261-5. PubMed ID: 2210385
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
13. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
Sasaki H; Watanabe T; Nomura S; Oishi M
Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
[TBL] [Abstract][Full Text] [Related]
14. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
Coppola JA; Parker JM; Schuler GD; Cole MD
Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
[TBL] [Abstract][Full Text] [Related]
15. c-Myc selectively regulates the latent period and erythroid-specific genes in murine erythroleukemia cell differentiation.
Shoji W; Ohmori Y; Obinata M
Jpn J Cancer Res; 1993 Aug; 84(8):885-92. PubMed ID: 8407552
[TBL] [Abstract][Full Text] [Related]
16. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
17. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
Kohlhuber F; Strobl LJ; Eick D
Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
[TBL] [Abstract][Full Text] [Related]
18. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
19. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.
Coppola JA; Cole MD
Nature; 1986 Apr 24-30; 320(6064):760-3. PubMed ID: 3458027
[TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
